title: [Clinicopathologic characteristics of eight patients with small cell carcinoma of the cervix].
abstract: OBJECTIVE
  To investigate the clinicopathologic characteristics, therapy and prognostic factors of small cell carcinoma of the cervix.
  
  
  METHODS
  Clinical and pathological data of eight patients were analyzed retrospectively.
  
  
  RESULTS
  Eight patients all presented with symptoms of abnormal vaginal bleeding or postcoital spotting. One patient had stage I b1 disease, 2 had stage I b2 disease, 2 had stage II b disease and 3 had stage III b disease. Histopathologic findings showed the small tumor cells had scant cytoplasm, round nuclei, absence of nucleoli, and finely dispersed chromatin. Immunohistochemical findings were positive in 7 cases for neuron-specific enolase. Three patients with stage I b disease and 1 patient with stage III b disease underwent radical hysterectomy and postoperative chemotherapy, with or without radiotherapy, and the survival period was 64, 22, 14 and 6 months respectively. Two patients with stage II b disease and 2 with stage III b disease underwent chemotherapy and radiotherapy, and the survival period was 25, 9, 10 and 5 months respectively.
  
  
  CONCLUSIONS
  Immunohistochemical analysis using several kinds of neuroendocrine markers is helpful in establishing the correct diagnosis in addition to focusing on characteristic histopathological features. It is necessary to use comprehensive treatment including surgery, chemotherapy and radiotherapy for patients with small cell carcinoma of the cervix. Chemotherapy may play an important role in the treatment.
authors.affiliation: Department of Gynecological Oncology, Cancer Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100021, China. chengfeidao@yahoo.com
authors.forename: Min
authors.initials: M
authors.lastname: Cheng
authors.forename: Ling-Ying
authors.initials: LY
authors.lastname: Wu
authors.forename: Ping
authors.initials: P
authors.lastname: Bai
authors.forename: Rong
authors.initials: R
authors.lastname: Zhang
authors.forename: Shan
authors.initials: S
authors.lastname: Zheng
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D014408:Biomarkers, Tumor; D018288:Carcinoma, Small Cell / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007044:Hysterectomy; D007150:Immunohistochemistry; D008197:Lymph Node Excision; D008853:Microscopy; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D012189:Retrospective Studies; D015996:Survival Rate; D002583:Uterine Cervical Neoplasms / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D055815:Young Adult
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor